MedPath

The Effect of Laser Power and Fiber Traction Speed on the Outcomes of Endovenous Laser Ablation

Not Applicable
Completed
Conditions
Varicose Veins
Registration Number
NCT03037827
Lead Sponsor
Clinic of Phlebology and Laser Surgery, Chelyabinsk, Russia
Brief Summary

A multicenter clinical randomized controlled trial, comparing of three different regimens of endovenous laser ablation with equal linear endovenous energy density in patients with insufficiency of the great saphenous vein (GSV). The linear endovenous energy density (LEED) is the main value for standardization EVLA. From many studies, it is known the optimum value of the LEED. However, the same LEED may be obtained by varying the ratio between the laser power and the fiber pullback speed. Power decrease can allow to reduce the incidence of adverse effects of endovenous laser ablation, but keep high efficiency.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
203
Inclusion Criteria

Patients over 18 years old Insufficiency of the GSV measured with ultrasound imaging, reflux > 0.5 sec No prior treatment of the insufficient GSV Informed consent

Exclusion Criteria

Acute deep or superficial vein thrombosis Agenesis of deep vein system Vascular malformation or syndrome Post-thrombotic syndrome, occlusive type Pregnancy Phlebectomy on the thigh Immobility Allergy to lidocaine Arterial insufficiency

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
The number of participants with a fully obliterated target vein3 month

An ultrasound investigation of the treated vein to find out is the treated vein is fully obliterated or not, and to find out is there any pathological reflux in the vein.

Secondary Outcome Measures
NameTimeMethod
Pain scoreday 7

Pain (numeric rating scale)

Trial Locations

Locations (2)

Clinic of Phlebology and Laser Surgery

🇷🇺

Chelyabinsk, Russian Federation

GarantClinic

🇷🇺

Moscow, Russian Federation

Clinic of Phlebology and Laser Surgery
🇷🇺Chelyabinsk, Russian Federation

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.